OR WAIT null SECS
© 2022 MJH Life Sciences and Rheumatology Network. All rights reserved.
© 2022 MJH Life Sciences™ and Rheumatology Network. All rights reserved.
In this week's news roundup from Rheumatology Network, we feature a one-on-one interview with Dr. Michael Lewiecki.
July 06, 2022
Previous attempts to make associations between JIA and prenatal maternal infection is difficult due to the rarity of JIA diagnosis and recall bias.
June 30, 2022
Take a few minutes to check out Rheumatology Network's top expert interviews from Q2 2022.
June 10, 2022
Frédéric Lavie, MD, PhD, explains the results of the data presented at EULAR evaluating guselkumab for the treatment of psoriatic arthritis.
June 09, 2022
Terence Rooney, MD, explains the innovative research methods that Janssen utilizes and the benefits of precision medicine in the treatment of psoriatic arthritis.
Terence Rooney, MD, discusses recent findings indicating that guselkumab provided patients with psoriatic arthritis with sustained improvements in health-related quality of life through 2 years.
June 01, 2022
Massimo Radin, MD, PhD, explains how tailoring oral therapy in rheumatoid arthritis, via the TuTOR App, can improve medication adherence.
May 23, 2022
James Woody, MD, PhD, explains the benefits of treating Dupuytren’s disease with anti-tumor necrosis factor (TNF).
Janet E McDonagh, MD, FRCP explains the importance of obtaining both the patient and parent perspective in pediatric rheumatology.
May 19, 2022
Zachary S Wallace, MD, explains his approach to diagnosing and managing IgG4-related disease and some of the clinical trials that are on the horizon.
May 16, 2022
Leonard Calabrese, DO, explains the history of interferon history in rheumatology, immunology for the rheumatologist, and COVID-19 immunology regarding autoimmune and inflammatory manifestations.